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Abstract
Background: Upon ligand binding, cell surface signaling receptors are internalized through a process tightly regulated by
endocytic proteins and adaptor protein 2 (AP2) to orchestrate them. Although the molecular identities and roles of
endocytic proteins are becoming clearer, it is still unclear what determines the receptor endocytosis kinetics which is mainly
regulated by the accumulation of endocytic apparatus to the activated receptors.
Methodology/Principal Findings: Here we employed the kinetic analysis of endocytosis and adaptor recruitment to show
that m2, a subunit of AP2 interacts directly with phospholipase D (PLD)1, a receptor-associated signaling protein and this
facilitates the membrane recruitment of AP2 and the endocytosis of epidermal growth factor receptor (EGFR). We also
demonstrate that the PLD1-m2 interaction requires the binding of PLD1 with phosphatidic acid, its own product.
Conclusions/Significance: These results suggest that the temporal regulation of EGFR endocytosis is achieved by auto-
regulatory PLD1 which senses the receptor activation and triggers the translocation of AP2 near to the activated receptor.
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Introduction
The internalization of receptors is a complex process orches-
trated by multiple proteins including clathrin, endocytic proteins,
and adaptor proteins, which recruit their cargo into clathrin-
coated pits (CCPs) [1,2]. Heterotetrameric AP2, which contains a,
b2, m2, and s2 subunits is a key adaptor in clathrin-mediated
endocytosis (CME) [3]. It triggers clathrin assembly, recruits
endocytic accessory proteins, and interacts directly with internal-
ization motif of cargo molecules through its b2, a, and m2 subunit
respectively [4]. It has been generally accepted that AP2 complex
is required for the endocytosis of cell surface receptors. However, it
is still the subjects of debate how AP2 roles in the internalization of
activated receptor [5,6,7] and what determines the kinetics of AP2
recruitment to the activated receptor and receptor endocytosis.
Upon EGF binding, EGFR is activated and internalized from the
cell surface via clathrin coated pits by the action of endocytic
proteins [8]. PLD1 is a receptor-associated signaling enzyme
catalyzing the hydrolysis of phosphatidylcholine (PC) to choline
and phosphatidic acid (PA) [9].Although a previous study suggested
that the lipase activity of PLD1 might be involved in EGFR
endocytosis based on the overexpression strategy [10], direct
evidence for the involvement of endogenous PLD1 lipase activity
is lacking and the underlying mechanism is largely unknown.
In this study, we describe the role of PLD1 in the EGF
stimulation-induced AP2 translocation and its involvement in the
kinetic regulation of EGFR endocytosis. We propose that PLD1
roles as a membrane docking site for AP2 and that the functional
downstream target of PLD1 lipase activity is PLD1 itself. Our
findings provide novel insights into the unique working model of
PLD1 as a signaling timer for EGFR internalization.
Results
Wild type but not lipase inactive PLD1 facilitates EGFR
endocytosis
To investigate the involvement of endogenous PLD1 in EGFR
endocytosis, we designed siRNA for human PLD1 (siPLD1),
corresponding to the human PLD1a coding nucleotides 1455–1475,
and measured the internalization of EGFR in HeLa cells. The
designed siPLD1 successfully reduced the endogenous expression of
PLD1 to ,10% of the control (i.e., inhibition with luciferase siRNA:
siLuc) within 72 hours of transfection (data not shown). Cell surface
protein biotinylation studies showed that the EGF (20 nM)-induced
endocytosis of EGFR was significantly delayed in cells transfected with
s i P L D 1c o m p a r e dw i t ht h ec o n t r o l( F i g u r e1 A ;s e ea l s oF i g u r e1 Bf o r
quantitative analysis). The maximal attenuation of EGFR internali-
zation occurred after 2 min of EGF treatment. However, the
internalization of transferrin receptor (TfR), which constitutively
endocytoses through clathrin-coated pits, remained unchanged. The
125I-EFG internalization data strongly support the essential role of
PLD1 in EGFR internalization (Figure 1C). The strong inhibitory
effect of PLD1 depletion by siRNA on the uptake of was observed
during linear 3-min time course. The internalization rate constant (ke)
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7090of PLD1-depleted cells was 19.5% compared to control. To confirm
the role of PLD1 and to check the involvement of the lipase activity of
PLD1 in EGFR endocytosis, we transfected wild type or a lipase
inactive mutant PLD1 (K898R) after depleting the endogenous PLD1
from HeLa cells by siPLD1, and measured the internalization of
EGFR after 2 min of EGF treatment. The expression of wild type
PLD1 in PLD1-depleted HeLa cellsrestored the internalization rate of
EGFR. However, the expression of PLD1 (K898R) failed to recover
EGFR internalization rate (Figure 1D). These results suggest that
endogenous PLD1 facilitates the EGF-induced internalization of
EGFR in HeLa cells in a lipase activity-dependent manner.
PLD1 associates with the m2 subunit of AP2 in a
PA-dependent manner
The endocytosis of activated cell surface receptors is mediated
by an adaptor protein AP2 that recognizes them via its m2 subunit
and recruits dynamin, clathrin, and accessory proteins involved in
vesicle formation [4]. PLD1 localizes near EGFR in the plasma
membrane and is transiently activated upon EGF stimulation [11].
To understand the mechanism by which lipase activity of PLD1
facilitates EGFR endocytosis, we checked the possibility of EGF
stimulation-dependent complex formation between PLD1 and the
components of AP2. Interestingly, the m2 subunit of AP2 was
found to transiently interact with endogenous PLD1 after 1–2 min
of EGF stimulation in HeLa cells (Figure 2A). In contrast, the
lipase inactive mutant PLD1 (K898R), which could not enhance
EGFR endocytosis (see Figure 1C) failed to interact with m2 (data
not shown). To investigate the involvement of the lipase activity of
PLD1 in its binding to m2, we measured the kinetics of PLD1
activation under the same conditions after EGF treatment.
Figure 2B shows that the activity of PLD1 dramatically stimulated
after 1 min of EGF treatment which correlates well with the
kinetics of PLD1-m2 interaction. To confirm the lipase activity-
mediated interaction between PLD1 and m2, 1-butanol was used
to inhibit the PA production. PLD preferentially utilizes primary
alcohol (e.g., 1-butanol), but not tertiary alcohol (e.g., t-butanol),
over water to generate a phosphatidylalcohol (e.g., phosphatidyl-
butanol) instead of PA [12]. After 2 min of EGF stimulation, the
association between PLD1 and m2 was detected in control and t-
butanol treated cells, but not in 1-butanol treated cells (Figure 2C).
Taken together, these results suggest that the production of PA by
PLD1 is important for its interaction with m2.
Association with PA enhances the direct interaction
between PLD1 and m2
To test whether PLD1 directly interacts with m2 or not, in vitro
pull-down analysis was performed using purified PLD1 and
GST-m2. As shown in Figure 3A, GST-m2 was coprecipitated with
PLD1, indicating that m2 binds directly to PLD1. PLD1 is com-
posed of a phox homology (PX) domain, a pleckstrin homology
(PH) domain, a central loop, and the conserved region (CR) I-IV
[13]. To identify the region responsible for direct binding to m2,
we used GST fusion PLD1 fragments as shown schematically in
Figure S1A. The pull-down assay showed that the PH domain
bound to m2 (Figure S1B and S1C) via a region spanning amino
acids 296–312 (Figure S1D). Moreover, this m2-PLD1 PH domain
interaction was highly specific, as the PH domains of other
proteins did not show any binding to m2 (Figure S1E). When
immunoprecipitation was performed in HeLa cells that were
transfected with PLD1 constructs after depleting endogenous
PLD1, m2 bound to wild type PLD1, but not to R304A or R304K
mutant (Figure 3B). These results indicate that Arg 304 within the
PH domain of PLD1 is directly involved in interaction with m2.
Figure 1. Wild type but not lipase inactive PLD1 facilitates
EGFR endocytosis. (A) HeLa cells were transfected with control (Luc)
or PLD1 (PLD1) siRNA to deplete endogenously expressed PLD1. After
serum starvation for 12 h, EGF was treated at 20 nM for 0, 2, 5, or
10 min and biotinylation of cell surface proteins was performed.
Biotinylated (Cell surface) proteins were separated using streptavidin
beads and analyzed by western blotting. A representative immunoblot
of three independent experiments is shown. (B) Quantitation of EGFR
internalization in HeLa cells. The kinetics of the EGF-induced
internalization of EGFR in HeLa cells transfected with either luciferase
(closed circle) or PLD1 (open circle) siRNA. (C) HeLa cells depleted of
endogenous PLD1 were incubated with
125I-EGF at 37uC. ke valueswere
measured during linear 3-min time course and expressed as per cent of
the mean values obtained for control-transfected cells. The data
represent mean values from three independent experiments and the
error bars represent standard deviations. (D) After depleting endoge-
nous PLD1 using PLD1 siRNA, endogenous level of wild type or K898R
PLD1 was expressed in HeLa cells. The internalization rate of EGFR was
calculated as described in (C) and is shown as a bar graph reflecting the
average of three independent experiments and standard deviations.
Immunoblots in the inset indicate the expression levels of the
constructs used.
doi:10.1371/journal.pone.0007090.g001
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dependent manner. (A) HeLa cells were treated with EGF (20 nM)
and cell extracts were immunoprecipitated with anti-PLD antibody and
then immunoblotted with the indicated antibodies. (B) The kinetic of
EGF-induced PLD1 activation in HeLa cells. (C) HeLa cells were treated
with EGF (20 nM) for 1 min in the absence or presence of either 1-
butanol (0.4%) or t-butanol (0.4%) as shown and then the cell lysates
were immunoprecipitated as in (A). Alcohols were added 5 min prior to
EGF treatment.
doi:10.1371/journal.pone.0007090.g002
Figure 3. Association with PA enhances the direct interaction
between PLD1 and m2. (A) Purified PLD1 immobilized with anti-PLD
antibody (PLD) or with pre-immune serum (CTL) was incubated with
purified GST alone or GST-m2. (B) HeLa cells expressing vector, wild type,
R304A, or R304K PLD1 were grown in DMEM containing 10% fetal
bovine serum. Cells were lysed and immunoprecipitated with anti-PLD
antibody. (C) Purified PLD1 immobilized with anti-PLD antibody was
incubated with purified GST alone or GST-m2 in the absence or presence
of C6-PA at the indicated concentrations. (D) Vector, wild type, K898R,
or R158Q PLD1 transiently expressed in HeLa cells was immunoprecip-
itated and incubated with purified GST-m2 in the absence or presence of
20 nM of C6-PA.
doi:10.1371/journal.pone.0007090.g003
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interaction between PLD1 and m2. Stahelin et al. [14] suggested
that the PX domain of PLD1 has a binding pocket for anionic
phospholipids such as PA. Thus, we hypothesized that the
occupation of the PX domain by PA generated by the activation
of PLD1 might contribute to the binding of the PH domain and
m2. To explore this possibility, we checked the effect of PA on the
PLD1-m2 interaction using exogenous PA, and found that PA
increased this interaction in a dose-dependent manner (Figure 3C).
Furthermore, the addition of 20 nM of PA induced binding
between m2 and the lipase inactive mutant PLD1 (K898R), as
shown in Figure 3D. Interestingly, PLD1 (R158Q) mutant, which
has full lipase activity (data not shown) but reduced affinity for PA
[14], could not interact with m2 in the presence of 20 nM of PA.
These results indicate that PLD1 is a direct target of PA, its own
product, and that the PA binding enhances its interaction with m2.
The PLD1-m2 interaction is important for adaptor
recruitment onto membranes
AP2 localizes to the cytosol when cells are in an un-stimulated
state, thus AP2 should translocate onto the plasma membrane
before it acts as an adaptor linking EGFR to the endocytic
machinery [15]. Also, it is generally accepted that recognition of
EGFR by m2 is an essential process in the clathrin-mediated
endocytosis of EGFR [4]. To understand the role of PLD1-m2
interaction in EGFR endocytosis, we first performed in vitro
membrane recruitment analysis using membrane preparation of
wild type PLD1 and rat brain cytosol. The addition of purified
PLD1 fragment (296–312) corresponding to the region involved in
m2 binding abolished the positive effect of wild type PLD1 on the
recruitment of m2 onto the membrane in a dose-dependent
manner (Figure 4A); however, the same fragment carrying the
R304A mutation had no effect. To confirm this, we performed
adaptor recruitment analysis in cells. HeLa cells depleted of
endogenous PLD1 were transfected with wild type, K898R,
R158Q, or R304A PLD1 and the localization of endocytic
proteins were monitored after 2 min of EGF treatment. Wild type
PLD1, but none of the mutants with little affinity for m2 (i.e.,
K898R, R158Q, and R304A), enhanced the recruitment of m2, a-
subunit of AP2 (a-adaptin), and clathrin heavy chain (CHC) onto
membrane (Figure 4B). These results suggest that the interaction
between PLD1 and its reaction product PA promotes the
recruitment of adaptors to membranes by enhancing the
interaction between PLD1 and m2.
PLD1-m2 interaction is important for PLD1-mediated
EGFR endocytosis
Upon EGF stimulation, m2 translocates onto the plasma
membrane and recognizes EGFR. So we checked the role of
PLD1 in the m2-EGFR interaction. EGF-dependent EGFR-m2
association was observed in wild type PLD1-transfected cells, but
not in cells transfected with PLD1 (R304A), PLD1 (R158Q), or
PLD1 (K898R) although these PLD1 constructs exist in EGFR
complex (Figure 5A). Next, we measured the internalization rate of
EGFR during 3 min of EGF treatment. Cells expressing PLD1
(R304A), PLD1 (R158Q), or PLD1 (K898R) neither of which
could interact with m2 showed about 20% of EGFR internalization
rate compared to wild type PLD1-expressing cells (Figure 5B).
These PLD1 constructs were expressed in comparable levels in
cells (Figure 5B, inset) and had comparable lipase activity. In
addition, the transient expression of a PLD1 fragment 296–312
resulted in the potent inhibition of EGFR internalization rate
(Figure 5D) and the EGFR-m2 association (Figure 5C) although
this construct had little effect on the lipase activity of PLD. Taken
together, these results indicate that the interaction between PLD1
and m2 is a key determinant for the EGF-induced internalization
rate of EGFR in cells.
Discussion
PLD1 is a key factor in the regulation of EGFR endocytosis.
PLD1 is activated upon EGF stimulation and it hydrolyzes PC to
PA at the plasma membrane [16]. Nonetheless, the identity of PA
effector protein and the mechanism by which PA regulates the
EGFR endocytosis are still unknown. The present study shows that
PLD1 itself is an effector of PA and auto-regulatory interaction
between the PX domain of PLD1 and PA promotes the binding of
another domain of PLD1, the PH domain, with m2 and thereby
facilitates EGFR endocytosis. The findings that the PLD1-m2
association is dependent on its lipase activity and that the effector
of PA is PLD1 itself establish the key role of PLD1 in EGFR
endocytosis and also provide new mechanistic insight. To our
knowledge, this is the first example of an auto-regulatory
mechanism for a signaling enzyme.
On the basis of our results, we propose that PLD1 is a complex
molecular device with functional triad composed of catalytic, PX,
and PH domain, each of which senses and mediates discrete steps
of EGFR endocytosis (Figure 5E). In our model, the catalytic
domain of PLD1 first generates PA from PC in response to EGFR
Figure 4. The PLD1-m2 interaction is important for adaptor
recruitment onto membranes. (A) Purified GST-fusion PLD1 296–312
or PLD1 296–312 (R304A) was added to recruitment assay mixture
containing membrane preparation from wild type PLD1-expressing HeLa
cells and rat brain cytosol (10 mg/ml). Membrane-recruited m2w a s
detected by western blotting. Data are representative of two indepen-
dent experiments. (B) Translocation of endocytic proteins onto plasma
membrane was analyzed. HeLa cells transfected with vector, wild type,
K898R, R158Q, or R304A PLD1 were treated with EGF (20 nM) during
2 min and the membrane preparations were subjected to SDS-PAGE and
immunoblotted using the indicated antibodies.
doi:10.1371/journal.pone.0007090.g004
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senses the input indicating that EGFR has been activated. This in
turn may cause the conformational change of PLD1 to expose the
m2 binding site of the PH domain which generates the output
signal that triggers the translocation of AP2 to the plasma
membrane and the endocytosis of EGFR. Previously, we also
reported that the PX domain of PLD1 has GTPase activating
properties for dynamin and enhances the EGFR endocytosis at
lower concentration of EGF [17]. Therefore, PLD1 might be a
multifunctional hub protein for the control of EGFR endocytosis
speed in response to the strength of the outside EGF signal.
It is still unclear how the kinetics of receptor endocytosis is finely
regulated depending on the strength of receptor activation. In this
study, we found direct evidence linking receptor stimulation and
endocytic molecule recruitment. We observed that increased
concentration of EGF (20 nM)-induced PLD1 activation is
responsible for the translocation of endocytic adaptor protein
(Figure 4B) and that this is critically required to facilitate the
internalization of EGF receptor (Figure 5B. When EGF is present
at low concentrations, EGFR endocytosis occurs slowly (linear
increase, time for half internalization (t1/2) is about 5 min) and
under such conditions the GAP function of PLD1, which is
independent of its lipase activity, rather than its lipase activity is
mainly involved, because the amount of EGF is not enough to
induce PLD1 lipase activity. However, when EGF is present at
relatively high concentrations to turn on PLD activity, PLD1
performs an additional role in endocytosis (in addition to acting as
a GAP for dynamin) by acting as a membrane target for the
adaptor protein, which enables for a high-rate of internalization of
EGFR (highly saturated, t1/2<1.5 min). PLD2, an isoform of
PLD1, also roles in EGFR endocytosis by acting as GAP for
dynamin [17] (lipase activity-independent role) but not in lipase
activity-dependent manner because it does not interact with m2
(data not shown). These results imply that receptor endocytosis
utilizes the same molecules but has a regulatory mode that
depends on the amount of ligand.
The present study demonstrates that PA generated by PLD1
activation plays a pivotal role in the facilitated EGFR endocytosis.
PA roles in promoting the PLD1-m2 interaction and triggering the
membrane translocation of AP2 (see Figure 4B) through binding to
the PX domain of PLD1. Furthermore, a good correlation
between the activation kinetics of PLD1 and the kinetics of
PLD1-m2 interaction and EGFR endocytosis (see Figure 2B, 2A,
and 1A respectively) suggests that PLD1 controls the kinetics of
EGFR endocytosis through the generation of PA. It has been
proposed that PA stimulates PIP5-kinase which is primarily
Figure 5. PLD1-m2 interaction is important for PLD1-mediated
EGFR endocytosis. (A) The recognition of EGFR by m2 was analyzed
by western blotting. Cell extracts were immunoprecipitated with anti-
EGFR antibody and then immunoblotted using the indicated antibod-
ies. (B) HeLa cells were transfected with wild type, R304A, R158Q, or
K898R PLD1 after being depleted of endogenous PLD1. After 2 min of
EGF (20 nM) treatment, the internalization rate of EGFR was measured
as in Figure 1 (D). The PLD1 lipase activity was measured in a parallel
experiment. Immunoblot in the insets indicates the expression levels of
the constructs used. (C) and (D) The effect of PLD1-m2 interaction on
EGFR-m2 association (C) and EGFR internalization rate (D) was checked.
(E) Schematic representation of the proposed mechanism whereby
PLD1 facilitates EGFR endocytosis in an auto-regulatory manner. Upon
EGF stimulation, PLD1 is activated and generates PA. Association
between PLD1 and PA through the PX domain of PLD1 increases the
affinity of the interaction between the PH domain of PLD1 and m2. This
interaction enhances the translocation of AP2 onto the plasma
membrane and the recognition of EGFR by m2 facilitating EGFR
endocytosis.
doi:10.1371/journal.pone.0007090.g005
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phosphatidylinositol–4,5-bisphosphate (PIP2) [19] which plays a
pivotal role in receptor endocytosis. The level of PIP2 reaches a
maximum at the initiation of endocytosis [20] and it causes the
recruitment of endocytic proteins onto the plasma membrane
[21,22]. Recently it was also reported that activation of PIP5-
kinase through interaction with AP2 and local generation of PIP2
is important for the recruitment of endocytic machineries and
synaptic vesicle internalization [23]. Taken together, we propose
that PA generation by PLD1 activation is a key molecular event
that causes the local accumulation of PIP2 through direct
activation of PIP5-kinase and enhancing AP2-PIP5-kinase path-




Pairs of 21-nucleotide sense and antisense RNA oligomers which
correspond to human PLD1a coding nucleotides 1455–1475 were
chemically synthesized and annealed by Dharmacon Research, Inc.
The oligonucleotides for PLD1 were as follows: sense, 59-AAG
GUG GGA CGA CAA UGA GCA-39, and antisense, 59-UGC
UCA UUG UCG UCC CAC CUU-39. Luciferase GL2 duplex
(Dharmacon Research, Inc.) was used as negative control.
Cell culture and transfection
HeLa cells obtained from the American Type Culture
Collection were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) containing 100 units/ml penicillin, 100 mg/ml strepto-
mycin, and 10% fetal bovine serum (GIBCO-BRL). HeLa cells
were introduced with synthetic siRNA (20 nM duplex) for PLD1
using METAFECTENE
TM reagent (Biontex) according to the
manufacturer’s instructions and then cultured for 48 hours to
achieve PLD1 silencing. To express the PLD1 constructs, cells
were transiently expressed with rat-origin PLD1 cDNAs using
Lipofectamine Plus
TM reagent (Invitrogen) one day after siRNA
transfection.
Generation of plasmids and GST fusion proteins
R304A and R304K point mutants of PLD1 were generated by
mutating the arginine residue at 304 to Ala or Lys respectively.
Briefly, the R304A mutant was obtained using forward primer: 59-
TGA TAA TCT TTC AGC TAC ACT GAT TTT A-39 and
reverse primer: 59-TAA AAT CAG TGT AGC TGA AAG ATT
ATC A-39. A similar strategy was used to generate the R304K
mutant using forward primer: 59-TGA TAA TCT TTC AAA
AAC ACT GAT TTT A-39 and reverse primer: 59-TAA AAT
CAG TGT TTT TGA AAG ATT ATC A-39. The resulting
products were cloned into pCDNA3.1 (Invitrogen) or pEGFP-C1
(Clontech) vector. Glutathione S-transferase (GST) fusion proteins
were prepared using glutathione-Sepharose 4B (Amersham
Biosciences). GST fusion PH domains of PLCb1, IRS, and
dynamin were kindly provided by Dr. Brian K. Kay (The
University of Wisconsin, Madison, WI) and GST-m2 was generous
gift from Dr. Juan S. Bonifacino (National Institutes of Health,
Bethesda, MD).
In vitro binding analysis
In vitro binding was performed in 500 ml of buffer A (50 mM
Hepes-NaOH (pH 7.5), 3 mM MgCl2, 2 mM CaCl2,3 m M
EGTA, and 80 mM KCl) containing 1% Triton X-100 at 4uC for
3 h. In experiments adding C6-PA (Avanti Polar Lipids), pellets
were washed with buffer A containing the same concentrations of
C6-PA used in the incubation.
Immunoprecipitation and western blotting
For immunoprecipitation, HeLa cells were serum starved for
12 h, treated with EGF (20 nM) (Daewoong Pharmaceutical Co.),
and lysed by sonication with buffer A containing protease
inhibitors, 1% Triton X-100, and 1% cholic acid. Cell lysates
were centrifuged at 100,000 g for 30 min at 4uC and the same
amounts of supernatant were incubated with anti-PLD [24] or
anti-EGFR (Upstate Biotechnology) antibody immobilized on
Protein A-Sepharose beads (Amersham Biosciences). For immu-
noblotting, anti-m2 (BD Transduction Laboratories), anti-a-
adaptin (BD Transduction Laboratories), anti-clathrin heavy chain
(BD Pharmingen), and anti-GST (Santa Cruz Biotechnology, Inc.)
antibodies were used. Horseradish peroxidase-conjugated goat anti-
rabbit or goat anti-mouse antibodies were purchased from
Kirkegaard and Perry Laboratories Inc. Proteins were visualized
by chemiluminescence using Enhanced Chemiluminescence kit
(Amersham Bioscience).
In vitro adaptor recruitment assays
HeLa cells transfected with wild type PLD1 were homogenized
with buffer B (buffer A with protease inhibitors and 0.25 M
sucrose) using a Dounce homogenizer and then sonicated. A
postmitochondrial supernatant was prepared by centrifuging the
homogenate at 1500 g for 10 min and the resulting supernatant
was further centrifuged at 100,000 g for 15 min in a TL-100.2
rotor (Beckman Instruments). After washing with buffer B,
membrane pellets were resuspended in 50 ml of rat brain cytosol
(10 mg/ml) prepared in buffer A containing protease inhibitors.
After 15 min at 37uC, reactions were stopped by adding 1 ml of
cold buffer A and membranes were collected by centrifugation as
described above. Pellets were resuspended in 50 ml of Laemmli
sample buffer and 10 ml aliquots were subjected to SDS-PAGE
and western blotting.
Adaptor recruitment assays in cells
Recruitment of endocytic proteins onto cell membranes was
performed as described below. After depletion of endogenous
PLD1, HeLa cells were transfected with vector, wild type, K898R,
R158Q, or R304A PLD1. The cells were then treated with EGF
(20 nM) during 2 min and washed twice with ice-cold buffer A.
Preparation of cell membrane was performed as described in ‘‘In
vitro adaptor recruitment assays.’’ After washing with buffer B,
membrane pellets were resuspended in 50 ml of Laemmli sample
buffer and 10 ml aliquots were subjected to SDS-PAGE and
western blotting.
Internalization of EGFR
HeLa cells grown in 60 mm dishes were starved for 12 h and
EGF (20 nM) was treated. Cells were washed twice with ice-cold
PBS containing 0.1 mM CaCl2 and 1 mM MgCl2 (PBS
2+) and
incubated with 1 mg/ml Sulfo-NHS-SS-biotin (Pierce) for 30 min
at 4uC. Nonreactive biotin was quenched with ice-cold PBS
2+ and
0.1 M glycine for 20 min at 4uC. The cells were then lysed with
radioimmunoprecipitation assay (RIPA) buffer (10 mM Tris
(pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton
X-100, and 1% sodium deoxycholate) containing protease
inhibitors and protein concentrations were determined. Biotiny-
lated and nonbiotinylated proteins were separated from equal
amounts of cellular protein by incubation with Immunopure
immobilized streptavidin (Pierce) for 4 h at 4uC. The biotin-
PLD1 and EGFR Endocytosis
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and washed five times with RIPA buffer. Proteins bound to beads
were eluted in Laemmli sample buffer and analyzed by SDS-
PAGE and western blotting. The ratio of internalized EGFR was
determined by densitometric analysis.
Internalization of
125I-EGF
HeLa cells grown in 12-well dishes were treated with
125I-EGF
at 37uC and the ratio of internalized and surface radioactivity was
determined during linear 3-min to calculate the specific internal-
ization rate constant ke as described previously [7].
In vivo PLD activity assays
PLD activity analysis was performed as previously described
[25]. After 24 h of fasting, the HeLa cells were incubated with
10 mCi [
3H]myristic acid (PerkinElmer Life Sciences) for 3 h. PLD
activity was determined using the transphosphatidylation reaction
in the presence of 0.4% 1-butanol. Lipids were extracted and
separated by Silica Gel 60 thin-layer chromatography (chloroform:
methanol: acetic acid, 90:10:10 volume ratio), and the amounts of
labeled phosphatidylbutanol and total lipid were determined using
a Fuji BAS-2000 image analyzer (Fuji Film).
Supporting Information
Figure S1 Binding region mapping of PLD1 for m2. (A)
Schematic depictions of PLD1 fragments. (B–E) The interaction
between PLD1 and m2 was analyzed by pull-down assay and
western blotting. The same amounts of GST alone or GST fusion
PLD1 fragments (B), PLD1 PX domain and the PH domain (C),
fragments of the PLD1 PH domain (D), and PH domains from
PLD1, PLCb-1, IRS-1, and dynamin-1 (E) were incubated with
purified m2.
Found at: doi:10.1371/journal.pone.0007090.s001 (0.73 MB TIF)
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